Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
Public ClinicalTrials.gov record NCT04212169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI3506 in Adult Subjects With Moderate-to-severe Atopic Dermatitis
Study identification
- NCT ID
- NCT04212169
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 148 participants
Conditions and interventions
Conditions
Interventions
- MEDI3506 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2019
- Primary completion
- Jul 20, 2022
- Completion
- Sep 19, 2022
- Last update posted
- Sep 27, 2023
2019 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35209 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Jacksonville | Florida | 32256 | — |
| Research Site | Miami | Florida | 33180 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Baton Rouge | Louisiana | 70808 | — |
| Research Site | Charlotte | North Carolina | 28277 | — |
| Research Site | Tulsa | Oklahoma | 74136 | — |
| Research Site | Providence | Rhode Island | 02903 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | San Antonio | Texas | 78213 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04212169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2023 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04212169 live on ClinicalTrials.gov.